Saturday, Oct 23, 2021 | Last Update : 08:07 PM IST

Covaxin human trial

Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases

03 Jul 2021 10:50 AM

AA Edit | Govt needs to do more to push vaccine awareness

It looks like the government has taken one area for granted -- public awareness about the vaccine

08 Dec 2020 7:26 AM

Bharat Biotech’s Covaxin shows ‘encouraging results’ in phase-I of human trials

Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India

27 Jul 2020 3:21 PM

ADVERTISEMENT
ADVERTISEMENT